Clinical Trial Update: Photodynamic Diagnosis for Malignant Brain Glioma With 5-Aminolevulinic Acid（5-ALA） [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating photodynamic diagnosis with 5-aminolevulinic acid (5-ALA) for malignant glioma of the brain has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Malignant Glioma

Drugs mentioned

• 5-aminolevulinic acid (5-ALA) (5-aminolevulinic acid)

Snippet

Sponsor: Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. | Conditions: 5-aminolevulinic Acid, Malignant Glioma of Brain | Phase 3 | Status: COMPLETED